US6461613B2
University of Texas System
Methods for inhibiting the production of specific vasoconstrictive prostanoids, such as thromboxane and prostaglandin F2alpha, through the addition of insulin like growth factor, particularly IGF-I or IGF-II, to human placental cells are disclosed. IGF-I is demonstrated to avoid affecting material …